NAS
DGX icon

Nykredit A/S’s Quest Diagnostics DGX Stock Holding History

Nykredit A/S’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.19M Buy
+33,940
New +$6.66M 0.02% 451

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Nykredit A/S's DGX Position: Q2 2026 in Review

Nykredit A/S opened a new position in Quest Diagnostics (DGX) in Q2 2026: 33,940 shares worth $7.19M. The stake represents 0.02% of the portfolio and ranks #451 among its holdings.

894 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Nykredit A/S held 33,940 shares of Quest Diagnostics worth $7.19M as of Q2 2026.
  • Quest Diagnostics was a new Nykredit A/S position in Q2 2026.
  • Quest Diagnostics made up 0.02% of Nykredit A/S's portfolio in Q2 2026, its #451 holding.
  • 894 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.